Patents by Inventor Michael Pontecorvo

Michael Pontecorvo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of galantamine for the treatment of neuropsychiatric behaviour associated with Alzheimer's disease
    Publication number: 20060172993
    Abstract: Galantamine has be used in the treatment of a number of chronic diseases. Galantamine has been found to be safe and effective in the treatment of Alzheimer's disease. Neuropsychiatric disorders are often associated with Alzheimer's disease. It is demonstrated that galantamine is also effective in reducing or stabilizing the incidence of neuropsychiatric behaviour seen in Alzheimer's patients.
    Type: Application
    Filed: April 3, 2006
    Publication date: August 3, 2006
    Inventors: Wim Louis Parys, Michael Pontecorvo
  • Use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease
    Publication number: 20040067934
    Abstract: Galantamine has be used in the treatment of a number of chronic diseases. Galantamine has been found to be safe and effective in the treatment of Alzheimer's disease. Neuropsychiatric disorders are often associated with Alzheimer's disease. It is demonstrated that galantamine is also effective in reducing or stabilizing the incidence of neuropsychiatric behaviour seen in Alzheimer's patients.
    Type: Application
    Filed: October 3, 2002
    Publication date: April 8, 2004
    Inventors: Wim Louis Julien Parys, Michael Pontecorvo
  • Efficacious dosage regimen of galantamine that reduces side effects
    Publication number: 20030139391
    Abstract: Galantamine has be used in the treatment of a number of chronic diseases. The use of this drug is associated with side effects such as, nausea or vomiting, and headaches. It has been demonstrated that by slowly introducing the patient to the drug these side effects can be reduced. It has also been shown that this slower titration results in the ability to use a lower effective dose of the drug.
    Type: Application
    Filed: October 3, 2002
    Publication date: July 24, 2003
    Inventors: Wim Louis Julien Parys, Michael Pontecorvo